-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622.O2.6 622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Genomic and Epigenetic Landscapes of Lymphoid Malignancies

Non-Hodgkin Lymphoma: Biology, excluding Therapy Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 10:30 AM-12:00 PM
W311EFGH, Level 3 (Orange County Convention Center)
Moderators:
Selina Chen-Kiang, PhD, Weill-Cornell Medical College and Kojo S. J. Elenitoba-Johnson, M.D., University of Pennsylvania

Disclosures:
No relevant conflicts of interest to declare.
10:30 AM

Deepak Bararia, PhD1*, Michael Heide1*, Robert S. Welner, PhD2*, Tatiana Romashova1*, Alessandro Pastore, MD3*, Radhika Mathur4*, Randy D. Gascoyne5, Robert Kridel, MD, MPH6, Boris G. Willson, PhD7*, Charles W.M. Roberts, MD, PhD4*, Wolfgang Hiddemann, MD, PhD1*, David M Weinstock, MD8 and Oliver Weigert, MD1

1Department of Internal Medicine III, Ludwig-Maximilians University of Munich, Munich, Germany
2Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5British Columbia Cancer Agency, Vancouver, BC, Canada
6Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
7Molecular Medicine Unit, Oncology R&D, GlaxoSmithKline, Collegeville, PA
8Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

10:45 AM

Makoto Yamagishi, Ph.D.1*, Dai Fujikawa1*, Daisuke Honma, Ph.D.2*, Nobuaki Adachi, Ph.D.2*, Shota Nakagawa1*, Makoto Hori1*, Naoya Kurokawa1*, Ai Soejima1*, Kazumi Nakano, Ph.D.1*, Tadanori Yamochi, Ph.D.1*, Makoto Nakashima1*, Seiichiro Kobayashi, M.D., Ph.D.3, Yuetsu Tanaka, M.D., Ph.D.4*, Masako Iwanaga, M.D., Ph.D.5, Atae Utsunomiya, M.D., Ph.D.6, Kaoru Uchimaru, M.D., Ph.D.3*, Kunihiro Tsukasaki, M.D., Ph.D.7, Kazushi Araki, D.V.M., Ph.D.2* and Toshiki Watanabe, M.D., Ph.D.1*

1Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
2Oncology Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan
3The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Graduate School and Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
5Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
6Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
7Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan

11:00 AM

Teresa Palomero, PhD1,2, Ana Carolina da Silva Almeida, PhD2*, Francesco Abate, PhD3*, Hossein Khiabanian, PhD3*, Estela Martinez-Escala, MD4*, Joan Guitart, MD4*, Cornelis P. Tensen, MD5*, Maarten H. Vermeer, MD, PhD5*, Raul Rabadan, PhD3* and Adolfo A. Ferrando, MD, PhD1,2,6

1Department of Pathology, Columbia University, New York, NY
2Institute for Cancer Genetics, Columbia University, New York, NY
3Department of Biomedical Informatics, Columbia University, New York, NY
4Department of Dermatology and Pathology, Northwestern University Feinberg Medical School, Chicago, IL
5Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands
6Department of Pediatrics, Columbia University, New York, NY

11:15 AM

Todd A Fehniger, MD, PhD, Kilannin Krysiak, PhD, Brian S White, PhD*, Matthew Matlock*, Chris Miller*, Robert Fulton, PhD*, Friederike Kreisel, MD, Catrina Fronick*, Lisa Cook*, Joelle Veizer*, Amanda F. Cashen, MD, Kenneth R Carson, MD, PhD, Melissa M Berrien-Elliott, PhD*, Nancy L Bartlett, MD, Richard K Wilson, PhD*, Elaine R Mardis, PhD*, Timothy J Ley, Malachi Griffith* and Obi L Griffith*

Washington University School of Medicine, Saint Louis, MO

11:30 AM

Sarah Lynn Ondrejka, DO1, Andrea B. Moffitt2*, Eric Tse, MBBS, PhD3, Eric D. Hsi, MD4, John R. Goodlad, MD5*, Rex au-Yeung6*, Yok-Lam Kwong6*, Gopesh Srivastava6*, Randy D. Gascoyne7, Deepthi Rajagopalan2*, Cassandra Love2* and Sandeep Dave, MD8

1Cleveland Clinic, Cleveland, OH
2Duke University, Durham, NC
3Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
4Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH
5Western General Hospital, Edinburgh, United Kingdom
6Hong Kong University, Hong Kong, China
7British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
8Duke Cancer Institute, Duke University Medical Center, Durham, NC

11:45 AM

Maurice Reimann, Dr.1*, Sven Masswig1*, Kolja Schleich, Dr.1*, Andrea Herrmann1*, Philipp Lohneis, MD2*, Jens Schrezenmeier1*, Bernd Dörken, Prof.1,3* and Clemens Schmitt1,3

1Medical Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Charité Universitätsmedizin Berlin, Berlin, Germany
2Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany
3Max-Delbruck Center for Molecular Medicine, Berlin, Germany

*signifies non-member of ASH